Chair(s):
Audrey Holtzinger, Evotec, Germany
,

Organized by: Evotec

This session will highlight recent advances in the development of PSC-derived regenerative therapies across three representative clinical indications: hearing loss, diabetes, and liver fibrosis. By showcasing diverse therapeutic formats, including well-defined single-cell populations for precise cell replacement, multicellular clusters that capture greater tissue complexity, and organoids designed for functional tissue repair, speakers will discuss strategies for directing PSCs into specific cell types as well as key translational challenges.

02:15 PM - 02:30 PM

Information
WELCOME AND INTRODUCTION | Audrey Holtzinger, Evotec, Germany

02:30 PM - 02:55 PM

Information
Terri Gaskell, Rinri Therapeutics, UK

02:55 PM - 03:20 PM

Information
M. Cristina Nostro, McEwen Stem Cell Institute, UHN, and University of Toronto, Canada

03:20 PM - 03:45 PM

Information
Tomomi Tadokoro, Tokyo University of Agriculture, Japan